Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$58.53 -1.47 (-2.45%)
As of: Oct 1, 2026 · 3:55 PM EDT

Biomarin Pharmaceutical (BMRN) Cash from Operations (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) recorded Cash from Operations of $168.11 million in Q2 2026, down 9.3% from $185.27 million a year earlier and down 23.8% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Cash from Operations (2009 - 2026) Analysis & Trends

On a TTM basis, Biomarin Pharmaceutical's Cash from Operations came in at $857.09 million as of Jun 30, 2026, up 11.8% year-over-year; for FY2025, it came in at $827.99 million, up 44.5% from FY2024.

  • Annual Cash from Operations has a five-year compound annual growth rate of 57.5% (FY2020 to FY2025).
  • Across earlier years, Cash from Operations came in at $572.84 million in FY2024 (+259.7%), $159.26 million in FY2023 (-9.5%), $175.9 million in FY2022 (-42.2%) and $304.54 million in FY2021 (+256.7%).
  • Quarterly Cash from Operations has ranged from -$73.93 million in Q1 2023 to $368.69 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash from Operations rose in six of the last eight quarters, with growth averaging 125.4%.
  • Peak year-over-year performance for Cash from Operations in the last five years was growth of 575.4% in Q4 2024, against a decline of 46.3% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $220.65 million (Q1 2026), $99.64 million (Q4 2025) and $368.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 168.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168.11 Mn
Mar 31, 2026 220.65 Mn
Dec 31, 2025 99.64 Mn
Sep 30, 2025 368.69 Mn
Jun 30, 2025 185.27 Mn
Mar 31, 2025 174.39 Mn
Dec 31, 2024 185.63 Mn
Sep 30, 2024 221.48 Mn
Jun 30, 2024 118.76 Mn
Mar 31, 2024 46.97 Mn
Dec 31, 2023 27.48 Mn
Sep 30, 2023 135.65 Mn
Jun 30, 2023 70.06 Mn
Mar 31, 2023 -73.93 Mn
Dec 31, 2022 6.79 Mn
Sep 30, 2022 158.32 Mn
Jun 30, 2022 56.23 Mn
Mar 31, 2022 -45.43 Mn
Dec 31, 2021 11.18 Mn
Sep 30, 2021 97.06 Mn
API Access

Biomarin Pharmaceutical Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BMRN&period=max&api_key=YOUR_API_KEY